Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
56 /100
HIGH RISK
Score updated Oct 13, 2026

MENS — Jyong Biotech Ltd. Dilution Risk Tracker

Track MENS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MENS — Get alerts when the score changes →

As of October 13, 2026, Jyong Biotech Ltd. (MENS) has a DilutionWatch DilutionScore of 56/100, rated HIGH dilution risk. Jyong Biotech Ltd. has a market capitalization of $159.66M, 76.03M shares outstanding, 17 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
85
📊 Float Risk
57
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 22%
💰 Capital Raise model 35%
• Low cash runway: 5 months remaining
🔄 Reverse Split model est. 15%
• Only 5 months cash — financial pressure
🔔 Track MENS — Get forecast alerts →

Market Data

Market Cap$159.66M
Shares Outstanding76.03M
Float26.94M
Cash$1.18M
Debt$17.46M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore56/100DilutionWatch score record
Shares Outstanding76.03MVerified float table or market cache
Public Float26.94MVerified float table or market cache
Market Cap$159.66MMarket data cache
Cash Runway4.6 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 0.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 29.9% shares (2026Q1 vs prior)
17 institutional holders · 484.6K shares
#1 BlackRock, Inc. 258.8K shares
#2 GEODE CAPITAL MANAGEMENT, LLC 64.2K shares
#3 UBS Group AG 37.4K shares
+ 14 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest222.1K
Days to Cover4.0
% of Float0.8%
FINRA data as of Sep 30, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news available for this ticker.

DilutionScore History — Last 90 Days

MENS's DilutionScore has held steady at 56/100 (High risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202656/100HIGH89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

MENS shares outstanding have decreased 0.0% from 74.23M (Apr 2026) to 74.23M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 25, 202674.23M26.94M▼ 5.74%
May 23, 202674.23M28.58M▼ 2.36%
May 17, 202674.23M29.27M▲ 5.95%
Apr 23, 202674.23M27.63M▼ 0.01%
Apr 10, 202674.23M27.63M▼ 0.01%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track MENS Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment MENS files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking MENS — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for MENS
MENS FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.